In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the ...

A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...

Fintel reports that on September 24, 2024, Goldman Sachs initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Buy ...

“A cell type is a group of cells that are similar to each other and distinct from other groups of cells,” offers ...

Long known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system — even between ...

In a big scientific leap, researchers have successfully sequenced RNA from an extinct Tasmanian tiger specimen that is over a ...

Goldman Sachs has initiated coverage on Avidity Biosciences with a Buy rating and a $59 price target, citing ...

An accidental discovery turned into an unexpected success when a team of interdisciplinary BU researchers created a new and ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

In a compelling Genomic Press Interview published in Brain Medicine on September 25, 2024, Professor Hermona Soreq of the ...

RNA-sequencing has become a cornerstone in the study of gene expression, offering insights beyond mere mRNA transcript ...

A group of interdisciplinary Boston University researchers worked together to investigate the promising technology of self-amplifying RNA as a way to deliver lifesaving drugs and create more effective ...